Together, these results suggest that olivomycin A promotes PINK1-associated mitochondrial remodeling and clearance in renal cancer cells, particularly in those with mutant p53, although the precise degradation pathway remains to be determined. The gene discussed is TP53; the disease is renal carcinoma.